Halozyme Announces Roche's Ocrevus® Sc With Enhanze® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Halozyme宣佈,Roche的Ocrevus® Sc與Enhanze®獲得歐洲委員會批准,用於複發性和初級進行性多發性硬化症。
Halozyme Announces Roche's Ocrevus® Sc With Enhanze® Receives European Commission Approval for Relapsing and Primary Progressive Multiple Sclerosis
Halozyme宣佈,Roche的Ocrevus® Sc與Enhanze®獲得歐洲委員會批准,用於複發性和初級進行性多發性硬化症。
譯文內容由第三人軟體翻譯。